Probiotics: Strains, CFU Counts, and the Research Behind Each

Probiotics: Strains, CFU Counts, and the Research Behind Each

The global probiotic market is projected to exceed $90 billion by 2027, yet a significant portion of consumers buying probiotic supplements have no idea what strain they're taking, let alone why. A "50 billion CFU" label sounds impressive, but if those bacteria are the wrong species for your goal — or don't survive transit to your colon — you're effectively paying for expensive capsules with minimal return.

This guide breaks down the clinical evidence strain by strain, explains what CFU counts actually mean in a research context, and helps you understand what to look for when choosing a probiotic supplement tailored to your gut, immune, and metabolic health.

---

What CFU Count Actually Means — and What It Doesn't

CFU stands for colony-forming units, a measure of viable, living bacteria in a supplement at time of manufacture. Most clinical trials on probiotics test somewhere between 1 billion (1 × 10⁹) and 100 billion (1 × 10¹¹) CFUs per day, depending on the strain and condition being studied.

Here's what the research actually shows about CFU thresholds:

• More CFUs ≠ better outcomes. A Cochrane review on Lactobacillus rhamnosus GG for antibiotic-associated diarrhea found meaningful protection at doses as low as 1–2 billion CFUs per day (Szajewska & Kołodziej, Alimentary Pharmacology & Therapeutics 2015; PMID: 26365579).
• Survivability matters more than starting count. Many strains are destroyed by stomach acid before reaching the colon. Enteric-coated capsules, acid-resistant strains, and spore-forming bacteria (like Bacillus subtilis) are specifically engineered to survive the GI transit.
• CFU at time of manufacture vs. expiration is a critical distinction. A supplement listing 50 billion CFUs at manufacture may deliver far fewer by the time you take it, especially if stored improperly.

The bottom line: match your CFU dose to the specific condition and strain shown to work at that dose — not the highest number on a label.

---

Best Probiotic Strains Backed by Clinical Evidence

Not all probiotics are interchangeable. Probiotic effects are strain-specific, meaning Lactobacillus acidophilus NCFM and Lactobacillus acidophilus La-5 may have meaningfully different effects even though they share the same species name. Below are the strains with the strongest clinical evidence across the most relevant health categories.

*Lactobacillus rhamnosus* GG (LGG)

Probably the most studied probiotic strain in the world. LGG has demonstrated efficacy in reducing the duration of acute infectious diarrhea in children (Szajewska et al., Journal of Pediatric Gastroenterology and Nutrition 2007; PMID: 17460498) and in preventing antibiotic-associated diarrhea in adults (Hempel et al., JAMA 2012; PMID: 22571464). It also shows intestinal barrier-strengthening properties through upregulation of tight-junction proteins (Anderson et al., Journal of Nutrition 2010; PMID: 20375263).

*Bifidobacterium longum* and *Bifidobacterium infantis*

B. longum has been studied for its role in reducing anxiety and stress biomarkers. A 2019 randomized controlled trial in healthy adults found that B. longum 1714 supplementation reduced perceived stress and improved sleep quality versus placebo over a four-week period (Allen et al., Translational Psychiatry 2016; PMID: 27089181). B. infantis 35624 has been evaluated in IBS, with trials showing reductions in bloating, bowel dysfunction, and abdominal pain scores compared to placebo (Whorwell et al., American Journal of Gastroenterology 2006; PMID: 16863564).

*Lactobacillus plantarum* 299v

This strain is particularly well-studied for irritable bowel syndrome (IBS). A randomized, double-blind, placebo-controlled trial of 214 IBS patients demonstrated that L. plantarum 299v significantly reduced abdominal pain and bloating over four weeks compared to placebo (Ducrotté et al., World Journal of Gastroenterology 2012; PMID: 22654428). It also supports iron absorption — a lesser-known benefit relevant to people with borderline ferritin levels.

*Saccharomyces boulardii*

Technically a yeast, not a bacterium, S. boulardii is often categorized alongside probiotic supplements. It has robust evidence for preventing traveler's diarrhea and reducing recurrence of Clostridioides difficile infection (McFarland, Therapeutic Advances in Gastroenterology 2010; PMID: 21180595). Because it's a yeast, it's not affected by antibiotics, making it particularly useful during antibiotic courses.

*Lactobacillus acidophilus* NCFM

Frequently studied alongside Bifidobacterium lactis Bi-07 in combination trials. This pairing has shown improvements in bloating and stool frequency in IBS patients (Ringel-Kulka et al., Journal of Clinical Gastroenterology 2011; PMID: 21436725). For more on individual nutrient interactions that affect gut health, the clinical evidence for ashwagandha's effect on gut-brain signaling offers useful context on the microbiome-stress axis.

---

Lactobacillus Acidophilus: The Most Recognized Probiotic Species

Lactobacillus acidophilus is one of the most recognized probiotic strains in consumer supplements — and one of the most misunderstood. It colonizes the small intestine and produces lactic acid, which lowers intestinal pH and creates an environment hostile to pathogenic bacteria.

The clinical evidence for L. acidophilus is strongest in three areas:

1. Lactose digestion. A meta-analysis published in Critical Reviews in Food Science and Nutrition found that L. acidophilus supplementation significantly improved lactose digestion symptoms compared to placebo, likely by upregulating β-galactosidase activity in the gut (He et al., 2008; PMID: 18278651).
2. Vaginal microbiome health. L. acidophilus dominates a healthy vaginal microbiome. Oral and vaginal supplementation has been studied in the context of bacterial vaginosis prevention, with mixed but generally supportive evidence (Senok et al., Cochrane Database of Systematic Reviews 2009; PMID: 19160195).
3. Immune modulation. L. acidophilus NCFM has been shown to reduce the incidence and duration of common cold symptoms in a randomized trial of children, likely through enhanced natural killer cell activity and secretory IgA production (Leyer et al., Pediatrics 2009; PMID: 19651563).

When evaluating a probiotic supplement containing L. acidophilus, look for the strain designation (NCFM, La-5, DDS-1, etc.) because generic labeling without a strain code makes it impossible to match the product to specific clinical evidence.

---

Probiotic for Gut Health: What the Research Says About IBS, IBD, and Microbiome Diversity

The gut health applications of probiotics span a spectrum — from functional digestive complaints like IBS and bloating to more serious inflammatory conditions like Crohn's disease and ulcerative colitis. The evidence varies significantly by condition.

Irritable Bowel Syndrome (IBS): A 2018 meta-analysis of 53 randomized controlled trials concluded that multi-strain probiotics reduced global IBS symptoms and abdominal pain scores more consistently than single-strain products (Ford et al., Gut 2018; PMID: 29535176). The most effective combinations typically include at least one Lactobacillus and one Bifidobacterium species.

Inflammatory Bowel Disease (IBD): Evidence is more nuanced. E. coli Nissle 1917 has shown equivalence to mesalazine in maintaining remission in ulcerative colitis (Rembacken et al., Lancet 1999; PMID: 10460816), and VSL#3 (a high-dose multi-strain blend) demonstrated efficacy in pouchitis prevention (Gionchetti et al., Gastroenterology 2003; PMID: 12612565). Probiotics are not a replacement for prescribed IBD therapy — always consult a gastroenterologist.

Microbiome Diversity: Fermented foods consistently outperform fiber-only interventions in increasing microbiome diversity in healthy adults, according to a 2021 randomized trial from Stanford (Wastyk et al., Cell 2021; PMID: 34256014). Probiotic supplements contribute to functional support but may not permanently colonize the gut — their benefits often depend on consistent use and a dietary environment that supports microbial diversity.

For individuals whose wearable or lab data suggests metabolic dysfunction, inflammation markers, or poor sleep — all of which correlate with gut dysbiosis — a personalized supplement formula from Ones can incorporate probiotic support alongside targeted nutrients like optimal magnesium glycinate dosage for gut motility and sleep to address root causes simultaneously.

---

Multi-Strain vs. Single-Strain Probiotics: Which Works Better?

A common debate in probiotic research is whether combining multiple strains produces additive benefits or whether strains compete with each other for colonization sites.

The current consensus leans toward multi-strain superiority for general gut health, while single-strain products may be preferable when targeting a specific, well-studied condition (e.g., LGG specifically for antibiotic-associated diarrhea).

For people using personalized supplement platforms, a data-driven approach is particularly useful here. Rather than guessing which strains to combine, linking your microbiome markers, inflammation panel, and digestive symptoms to a recommendation engine removes a lot of the guesswork. Platforms like Ones are designed for exactly this: analyzing your inputs and building a formula around clinical-grade ingredients — not marketing claims.

---

Prebiotics, Postbiotics, and Synbiotics: The Supporting Cast

No probiotic discussion is complete without addressing the broader ecosystem:

• Prebiotics are non-digestible fibers (inulin, FOS, GOS) that feed beneficial bacteria. Combining probiotics with prebiotics into a synbiotic consistently outperforms probiotics alone in clinical trials measuring microbiome composition (Swanson et al., Nature Reviews Gastroenterology & Hepatology 2020; PMID: 32792570).
• Postbiotics are the metabolic byproducts of bacterial fermentation — short-chain fatty acids (SCFAs) like butyrate are the most studied, supporting colonocyte health and intestinal barrier integrity (Deleu et al., EBioMedicine 2021; PMID: 34147975).
• Spore-forming probiotics (Bacillus coagulans, Bacillus subtilis) survive stomach acid more reliably than most Lactobacillus strains and are increasingly included in clinical formulations. B. coagulans GBI-30, 6086 reduced abdominal pain and bloating in IBS patients in a randomized trial (Hun, Postgraduate Medicine 2009; PMID: 19820280).

If you're also exploring broader metabolic support, understanding vitamin D3 and K2 synergy in immune and gut health is a logical complement — vitamin D deficiency is consistently associated with altered gut microbiome composition.

---

What This Means for Your Formula

At Ones, probiotic support is integrated into a broader personalized supplement strategy based on your blood work, wearable data, and health history. Here's how specific Ones ingredients intersect with the gut health research above:

• Magnesium Glycinate (within the Magnesium Complex System Blend): Magnesium plays a direct role in gut motility, and deficiency is associated with constipation and altered microbiome composition. Ones delivers magnesium in its most bioavailable chelated form, matching doses used in clinical research — typically 200–400mg elemental magnesium daily.
• NAC (N-Acetylcysteine): NAC supports intestinal glutathione synthesis, which protects the gut epithelium from oxidative stress and supports mucosal barrier integrity. It's particularly relevant for individuals with inflammatory gut conditions or elevated hsCRP markers on their labs (Geier et al., Digestive Diseases and Sciences 2006; PMID: 16416184).
• Vitamin D3 + K2 (MK-7): Low vitamin D (25-OH-D below 30 ng/mL) is associated with increased intestinal permeability and dysbiosis. Ones includes D3 alongside MK-7 to ensure proper cofactor support — mirroring the synergistic dosing protocols studied in immune and gut health research.

For users with specific digestive health goals, Ones' AI practitioner can flag patterns in your lab markers — such as low ferritin (linked to reduced Lactobacillus colonization), elevated CRP (a dysbiosis signal), or abnormal lipid profiles that often co-occur with gut inflammation — and build a formula that addresses the whole picture, not just the probiotic layer.

When comparing personalized approaches: Viome focuses on microbiome sequencing with food and supplement recommendations; Thorne offers practitioner-grade single supplements without personalization; Ritual provides standardized subscription multivitamins. Ones differentiates by synthesizing lab data, wearables, and health history into a fully custom multi-ingredient capsule formula — not a generic stack.

To understand how omega-3 EPA and DHA ratios interact with gut inflammation markers, it's worth reviewing what your lipid and CRP data shows before finalizing any gut health protocol.

---

Key Takeaways

• CFU count is not the most important metric — strain specificity, survivability, and delivery mechanism matter more than the raw number on the label.
• Strain identity (not just species) determines clinical applicability — always look for a strain code like LGG, NCFM, or 299v, not just "Lactobacillus."
• Lactobacillus rhamnosus GG has the broadest and deepest evidence base for antibiotic-associated diarrhea and gut barrier support.
• Multi-strain probiotics outperform single-strain formulas for general IBS and microbiome diversity goals, while single strains may be preferable for targeted conditions.
• Synbiotics (probiotic + prebiotic combinations) consistently show superior outcomes to probiotics alone in studies measuring microbiome composition.
• A personalized approach — informed by actual lab markers, inflammatory indicators, and microbiome-adjacent data points — is more likely to produce meaningful gut health outcomes than a generic high-CFU capsule chosen off a store shelf.

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any new supplement protocol, especially if you have a diagnosed gastrointestinal condition or are taking prescription medications.